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Abstract
Introduction: Zygomatic implants are a good rehabilitation alternative for upper maxilla with severe bone reabsorp-
tion. These implants reduce the need for onlay-type bone grafting in the posterior sectors and for maxillary sinus 
lift procedures - limiting the use of bone grafts to the anterior zone of the upper jaw in those cases where grafting is 
considered necessary.
Objective: To evaluate the survival of 101 zygomatic implants placed in upper maxilla presenting important bone 
reabsorption, with a follow-up of 1-72 months.
Patients and methods: A retrospective study was made of 101 Zygoma® implants (Nobel Biocare, Göteborg, Sweden) 
placed in 54 patients with totally edentulous and atrophic upper maxilla, in the period between 1998-2004. There 
were 35 women and 19 men, subjected to rehabilitation in the form of fixed prostheses and overdentures using 1-2 
zygomatic implants and 2-7 implants in the anterior maxillary zone. The principal study variables were smoking, a 
history of sinusitis, the degree of bone reabsorption, and peri-implant bone loss, among others. 
Results: The descriptive analysis of the 101 zygomatic implants placed in 54 patients with a mean age of 56 years 
(range 38-75) yielded a percentage survival of 96.04%, with four failed implants that were removed (two before and 
two after prosthetic loading). Nine patients were smokers, and none of the 54 subjects reported a history of sinus 
disorders. 
Discussion and conclusions: Zygomatic implants are designed for use in compromised upper maxilla. They allow the 
clinician to shorten the treatment time, affording an interesting alternative for fixed prosthetic rehabilitation. This 
study confirms that zygomatic bone offers predictable anchorage and acceptable support function for prostheses in 
atrophic jaws. However, these implants are not without complications. Longer-term evaluations are needed of zygo-
matic implant survival in order to establish a correct clinical prognosis. 
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Introduction
Introduced by Brånemark in 1988, zygomatic implants 
were designed to rehabilitate atrophic upper maxilla, or 
upper jaws subjected to resection for oncological reasons, 
or with bone loss secondary to trauma. Their use has made 
it possible to reduce bone grafting procedures in patients 
seeking a permanent solution with a minimum number of 
surgical operations and the shortest treatment time possible 
- without losing the expectations for successful treatment.
The insertion of standard dental implants and the prepa-
ration of a prosthesis are limited in patients with atrophic 
upper jaws, due to the limited amount and quality of 
the available bone, as well as because of the presence of 
highly pneumatized maxillary sinuses. In these cases it is 
necessary to resort to advanced bone graft surgery, such 
as the bloc iliac crest Le Fort I osteotomy, onlay-type bone 
grafting techniques, or maxillary sinus lift procedures in 
the posterior sectors of the maxilla (1-4). These techni-
ques pose a series of inconveniences, such as the need for 
multiple surgical interventions, the use of extraoral bone 
donor sites (e.g., iliac crest or skull) - with the morbidity 
involved in surgery of these zones - and the long time for 
which patients remain without rehabilitation during the 
graft consolidation and healing interval (5). These factors 
complicate patient acceptance of the restorative treatment 
and limit the number of procedures carried out.
Zygomatic implants are an effective treatment alternative 
that reduces the use of bone graft procedures, employing 
the zygomatic bone as anchorage. When contemplating 
zygomatic implant rehabilitation, the patient must present 
not only posterior alveolar crest reabsorption precluding 
the placement of additional fixations for supporting the 
prosthesis, but also sufficient bone volume in the anterior 
zone of the upper jaw - with a minimum height of 10 
mm and a width of 4 mm - to allow the placement of 2-4 
conventional fixations. If  the bone volume in the anterior 
upper maxillary zone is insufficient, there must be ideal 
conditions for onlay-type bone grafting and guided bone 
regeneration (GBR) techniques.
Different therapeutic options are available for the rehabi-
litation of atrophic upper maxilla (6). Maxillary sinus lift 
procedures are accepted and are predictable for implant 
placement. In order to apply this technique, a bone donor 
site must be available. This site can be intraoral (chin, 
ascending mandibular ramus, retromolar trigone, etc.) or 
extraoral (iliac crest, skull, tibia, etc.), depending on the 
size of the maxillary sinus and on whether sinus lifting is 
to be uni- or bilateral. Depending on the remnant bone 
volume and quality as established by the classification 
of Lekholm and Zarb 1985 (7), maxillary sinus lift and 
implant placement are carried out in one or two phases. 
When the bone height is insufficient to secure the necessary 
primary implant stability (type 4 bone with type D or E 
reabsorption), bone grafting is performed in a first phase, 
followed 6 months later by implant placement (2). 
Lekholm et al. (8)conducted a multicenter retrospective 
study with a follow-up period of three years, involving 150 
patients with edentulous upper jaws that were treated with 
different bone grafting techniques (onlay, inlay, or using 
the Le fort I osteotomy plus bone grafting). These authors 
reported a 23% failure rate when placing the implants in 
the same surgical step as bone grafting, and a 10% failure 
rate when two surgical phases were used. The success rate 
of prosthetic rehabilitation in the patients was 85%. Keller 
et al. (9) presented the long-term results (with 12 years of 
follow-up) corresponding to 118 inlay autologous bone 
grafts placed in the nasal and sinusal zones in patients with 
compromised upper maxilla. The survival rate was 87%, 
while the correct prosthetic function rate was 95%. These 
procedures may require several surgical interventions, and 
the duration of treatment associated with such bone graf-
ting procedures, plus the time needed to prepare the defi-
nitive dental rehabilitation, is considerable. Nevertheless, 
the end results usually offer high percentage success rates. 
Zygomatic implants have been proposed to facilitate the 
treatment of atrophic upper maxilla, since they reduce the 
need for a range of surgical interventions, and moreover 
shorten the overall treatment time (10,11).
Different authors (12-15) have described the use of zygo-
matic implants for the functional and esthetic reconstruc-
tion of palatal deformities, post-maxillectomy defects or 
other mutilating disorders, and in developmental anoma-
lies of the craniofacial skeletal components (e.g., ectoder-
mal dysplasia) - with satisfactory results in all cases. 
The present study evaluates the survival of 101 zygomatic 
implants placed in upper maxilla presenting important 
bone reabsorption, with a follow-up period of  1-72 
months.
Patients and Methods
The 54 patients included in the present study were treated 
in the Branemark Osseointegration Center (BOC) of Bar-
celona (Spain) between February 1998 and January 2004. 
All were totally edentulous in the upper maxilla, with 
important bone reabsorption of the latter, and required 
a solution due to the lack of stability of the full dentures. 
In all patients the remnant bone was insufficient to allow 
conventional implant-based rehabilitation (Figure 1). 
The preoperative protocol comprised a blood test, en 
electrocardiogram and chest X-ray study to evaluate the 
general health of the patient. A clinical intraoral examina-
tion was carried out to discard infectious or inflammatory 
processes of the soft tissues (mucosa and gums). After 
evaluating the posterior region of the upper maxilla, 10 
patients were seen to present type IV maxillary bone re-
absorption, while 34 had type V reabsorption according 
to the classification of Cawood and Howell (16). 
The radiological study included a panoramic X-ray study 
and high-resolution computed tomography scan (HRTC) 
to assess the size and conformation of the zygomatic and 
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maxillary bone, and to discard possible maxillary sinus 
pathology.
The information collected from the clinical histories and 
radiological studies of  all patients comprised age, sex, 
smoking, antecedents of systemic disease, the degree of 
maxillary atrophy, the type of bone graft placed in the 
anterior maxillary sector, and the lengths of the zygomatic 
and standard implants, the type of prosthesis placed, the 
duration of postoperative follow-up, and the complica-
tions recorded over a period of 1-72 months.
The included patients were required to present reabsorp-
tion of the posterior sector of the upper jaw, though with 
sufficient bone in the anterior region to allow the place-
ment of at least two standard implants. Alternatively, the 
patients were required to present severe bone reabsorption 
amenable to simultaneous placement of bone grafts in the 
anterior zone.
A total of 101 Zygoma® implants (Nobel Biocare, Göten-
borg, Sweden) were used, together with 221 Brånemark 
System® standard implants (Nobel Biocare, Götenborg, 
Sweden). The Zygoma® implants were made of titanium 
with a self-threading machined surface, available in 8 di-
fferent lengths of between 30 and 52.5 mm. The implant 
diameter varied according to the portion close to the 
maxillary alveolar ridge (diameter = 4.5 mm) or the apical 
portion of the implant inserted in the zygomatic bone (dia-
meter = 4 mm). In order to compensate the inclination of 
implant insertion with respect to the zygoma, the implant 
head was angled 45º (Figure 2).
The 221 standard implants placed in the anterior zone 
of  the upper jaw were inserted following the protocol 
described by Brånemark et al. (7) A total of 219 regular 
platform (RP) and two wide platform (WP) conventional 
implants were used. 
The patients were operated upon under inhalatory ge-
neral anesthesia using sevoflurane (Sevorane®, Abbott, 
Madrid, Spain), with intravenous fentanyl (Fentanest® 
Kern Pharma, Barcelona, Spain). In addition, use was 
made of  local anesthesia (4% articaine with 1:100.000 
adrenaline) to block the superior alveolar nerves (pos-
terior, middle and anterior), and the palatal nerves (pos-
terior and nasopalatal). The upper maxilla was reached 
through a crestal incision allowing improved palatal access 
for implant placement. After raising the mucoperiosteal 
flap, soft tissue dissection was extended along the inferior 
and frontal lateral surfaces of the zygomatic bone, with 
identification of the infraorbital foramen. Special care was 
taken to avoid invading the orbit or sectioning the insertion 
of the masseter muscles in excess - as important bleeding 
could result. Following zygomatic dissection, the maxillary 
sinus was fenestrated, creating a 10 x 5 mm infrazygomatic 
window, while keeping the Schneider membrane intact. 
This window should allow visualization of drill entry to 
the zygomatic bone and the implant bed at the time of im-
plant placement. The palatal mucosa was then detached, 
visualizing the insertion trajectory from the zone of the 
second premolar / first molar to reach the zygomatic bone 
traversing the maxillary sinus. To avoid penetration of the 
Fig. 1. A) Preoperative panoramic X-ray view of a patient with maxillary atrophy. B) Postoperative panoramic X-ray view 
of rehabilitation with two zygomatic implants and three standard implants in the anterior zone of the upper maxilla.
Fig. 2. Zygoma® implant (Nobel Biocare, Götenborg, Sweden).
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The zygomatic implants in the totally edentulous patients 
were always accompanied by standard implant placement 
in the anterior sector of the upper jaw - surgical insertion 
depending on the available bone volume. In those cases 
where bone volume was considered insufficient, the process 
was accompanied by bone graft placement.
Simple sutures were placed, with horizontal mattress 
sutures to ensure correct flap closure, using reabsorbable 
4/0 polyglactin 910 suture material (Vicryl®, Johnson & 
Johnson, St. Stevens-Woluwe, Belgium).
Antibiotic (amoxicillin 750 mg, Normon®, Madrid, 
Spain, 1 tablet every 8 hours for 10 days), antiinflamma-
tory (diclofenac 50 mg, Normon®, Madrid, Spain, 1 tablet 
every 8 hours for 3 days) and analgesic medication was 
prescribed (metamizol 575 mg, Normon®, Madrid, Spain, 
2 capsules every 8 hours), together with rinses (0.12% 
chlorhexidine gluconate, Lacer®, Barcelona, Spain, twice 
daily for 15 days).
orbit, a soft tissue retractor was placed in the zygomatic 
angle. This retractor was used to indicate direction and 
moreover served as a stop. The drilling sequence started 
with a rounded drill or guide penetrating at palatine level. 
The trajectory through the maxillary sinus was followed, 
allowing visual control of the drill through the infrazygo-
matic window, with insertion in the zygomatic bone until 
the superior cortical layer was perforated. The drill was 
directed towards the Brånemark retractor previously po-
sitioned at a 90º angle with respect to the zygomatic bone. 
The drilling sequence was continued using a 2.9 mm helicoid 
drill, 2.9 and 3.5 mm pilot drills, and a 3.5 mm helicoid drill. 
Working of the alveolar portion was completed with a 4 
mm countersink drill, which is not advisable if very fine or 
fragile palatine bone is found. During drilling, and because 
of the length of the drills, the lower lip required protection in 
order to avoid possible injury or burns. Finally, the bed was 
measured, followed by implant placement until exceeding 
the upper cortical layer (17)(Figure 3).
Fig.3
Fig. 3. Surgical sequence. A) Edentulous alveolar ridge. B) Drilling through the maxillary sinus under visual control. C) 
Insertion of the 2.5 mm drill. D) Placement of the zygomatic implant and angulation of the implant head to correct its 
palatine emergence. E) Occlusal view with the dental implants in place. F) Frontal view of the first surgical phase.
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In all cases the sutures were removed one week after the 
operation. Posteriorly, clinical controls were made after 
1, 3 and 6 months, in preparation of the second phase of 
implant surgery, with panoramic X-ray control.
Following placement of the definitive prosthesis, the patients 
were seen yearly to assess soft tissue condition, perform a 
panoramic X-ray control, and evaluate occlusion. 
Zygomatic implant success was defined by the following 
criteria: clinical stability without signs of mobility; the 
absence of pain, infection or any other implant-related pa-
thology; the absence of peri-implant radiotransparencies; 
and a prosthetically favorable implant position.
In turn, zygomatic implant failure was defined as: evidence 
of implant osteointegration loss; implant fracture; and 
failure to meet the aforementioned success criteria.
The results were analyzed using the SPSS version 12.0 
statistical package for Microsoft Windows (license of the 
University of Barcelona, Spain).
Results
A total of 101 zygomatic implants were placed in 54 pa-
tients (35 women and 19 men), with a mean age of 56 years 
(range 38-75). All patients were completely edentulous in 
the upper jaw. Eight patients smoked over 10 cigarettes/
day, while one patient smoked fewer than 10 cigarettes/day. 
As regards the systemic disease antecedents of interest, 
three patients had suffered hepatitis C, two were hyper-
cholesterolemic, one was HIV-positive, another had high 
blood pressure, and one patient had undergone surgical 
resection due to squamous cell carcinoma.
In 25 of the 54 patients, the combination of zygomatic im-
plants with onlay- or inlay-type bone grafting and guided 
bone regeneration (GBR) in the same surgical step proved 
necessary (Table 1). In the remaining 29 patients we placed 
the zygomatic implants and the standard implants in the 
anterior zone of the upper maxilla. 
During the postoperative period, swelling in the infraorbi-
tal region with bruising were recorded in some cases. Pain 
proved mild to moderate, and was effectively treated with 
conventional analgesics.
The number of standard implants placed in the anterior 
sector of the jaw varied according to the anatomical charac-
teristics of the patient, and in all cases placement was made 
in seek of adequate mechanical stability for the prosthesis. 
In addition to the zygomatic implants, 2 standard dental 
implants were placed in 5 patients, 3 in 5 patients, 4 in 32 
patients, 5 and 5 patients, 6 in 6 patients, and 7 in one patient 
- yielding a total of 221 conventional implants. In 7 cases 
we placed a single zygomatic implant, with conventional-
technique implants on the contralateral side. The remaining 
47 patients received bilateral zygomatic implants. Table 2 
shows the distribution of zygomatic implant lengths.
Premaxillary bone 
grafting technique
Iliac 
crest
Skull Chin
Bovine 
bone + 
autologous 
bone
Total
Vestibular onlay 5 2 1 0 8
Crestal onlay 2 0 0 0 2
Vestibular + crestal 
onlay
4 2 0 0 6
Vestibular onlay + 
nasal inlay
1 0 0 0 1
Crestal onlay + 
nasal inlay
1 0 0 0 1
Vestibular onlay 
+ crestal onlay + 
nasal inlay
3 0 0 0 3
GBR 0 0 0 4 4
  Total 16 4 1 4 25
Length 30 
mm
35 
mm
40 
mm
42.5 
mm
45 
mm
47.5 
mm
50 
mm
52.5 
mm
Total
No. 
implants
0 10 27 16 8 24 16 0 101
Table 1. Bone grafting technique used in the anterior zone of the upper maxilla and 
donor zones.
Table 2. Distribution of the zygomatic implants used, according to length.
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All the zygomatic implants were placed using the two-
phase procedure. The mean osteointegration time was 
7.83 months (range 6-12). The 221 conventional implants 
placed in the maxilla (with a minimum of 2 and a maxi-
mum of 7 per patient) yielded a 93.22% success rate, with 
15 implant failures that did not adversely affect prosthesis 
design or stability.
In 25 cases a fixed prosthesis was placed, with hybrid pros-
theses in 20 cases. Nine patients in turn received overden-
tures supported by a bar joining the zygomatic implants 
with the implants located in the anterior sector.
All patients were subjected to the established controls from 
the first surgical phase onwards. During the follow-up 
period (Table 3), we recorded a total of four zygomatic im-
plant failures in female patients, together with one compli-
cation that caused important sinus infection episodes that 
were resolved by antibiotic treatment. Two of the failures 
occurred at the time of the second surgical phase, before 
prosthesis loading, as a result of a lack of bone integration. 
After 18 months of prosthetic loading, one smoker of over 
10 cigarettes/day with a fixed prosthesis supported by 6 
standard implants suffered peri-implantitis affecting one 
of the zygomatic implants. Posteriorly, after 43 months of 
loading, the fracture of one of the zygomatic implants was 
recorded in a patient with overdentures on three standard 
fixations. The four failures in four patients were regarded 
as implant failures, since the established success criteria 
were not met, and the zygomatic implants were removed 
without replacement. These patients retained a single zygo-
matic implant that proved able to support the prosthetic 
rehabilitation in combination with the fixations in the 
anterior sector of the maxilla. Patient reported satisfaction 
with the treatment was high from both the surgical and 
prosthetic perspective, with no discomfort attributable to 
the palatine emergence of the zygomatic implants.
Discussion
Our study yielded a zygomatic implant survival rate of 
96.04%, comparable to the results published by other 
authors such as Brånemark et al. (18), Hirsch et al. (10), 
Malevez et al. (19), Vrielinck et al. (20), Bedrossian et al. 
(21) and Nakai et al. (22). In effect, Brånemark et al. (18) 
recorded a survival rate of 94.2% with 52 Zygoma® im-
plants over a follow-up period of 5-10 years, in 28 patients 
with atrophic upper maxilla. Of the 106 conventional 
implants placed, a total of 29 failed (27%), and 17 patients 
required premaxillary bone grafting. Two of the three 
zygomatic implant failures occurred at the time of fitting 
of the prosthesis, and the other after 6 years of loading. 
In our series, four zygomatic implants failed and were re-
moved. Malevez et al. (19) published a retrospective study 
with a follow-up duration of 6-48 months of prosthetic 
loading, evaluating the survival rate of  103 zygomatic 
implants placed in 55 edentulous and severely reabsorbed 
upper maxilla. These authors reported a 100% zygomatic 
implant survival rate, with a single complication prior to 
prosthetic loading (severe sinus infection successfully trea-
ted with antibiotics). Bedrossian et al. (21) in turn reported 
100% survival in a series of 44 zygomatic implants in 22 
patients, with a 91.25% survival rate for the 80 standard 
implants placed in the anterior sector of the upper jaw. The 
observation period was 34 months, i.e., shorter than in our 
study. The authors reported that all patients underwent a 
postoperative period similar to that of patients subjected 
to conventional implant surgery (15).
Bothur et al. (23) described a modification of the standard 
zygomatic implant placement technique, using more than 
three implants on each side of the upper maxilla to support 
the dental prosthesis, and thus obviating the bone graft 
procedures in the premaxillary zone. It would be interes-
ting to know the long-term results in order to define the 
prognosis associated with this technique.
First 
surgical 
phase
Patients 
treated
Zygomatic 
implants 
placed
Failures Time of failure
1998 3 6 0 ----
1999 5 9 1
43 months post-
loading
2000 9 16 ----
2001 17 32 1 Second phase
2002 14 27 2
Second phase and 18 
months post-loading
2003 5 10 0 ----
2004 1 1 0 ----
Total 54 101 4 ----
Table 3. Follow-up of the patients in the series.
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There have been reports of speech alterations and pro-
blems for maintaining correct hygiene of the dental pros-
theses, largely as a result of the palatine emergence of the 
platform of the zygomatic implant (22). Boyes-Varley et 
al. (24) placed 30 zygomatic implants in 18 patients, mo-
difying the angulation of the implant head 55º in order to 
position emergence at alveolar crest level. According to 
the authors, this angulation of the implant head affords 
a cantilever reduction of over 20%, which in addition to 
improving the space required for tongue movement allows 
the patient better access for adequate maintenance of the 
dental prosthesis.
Nkenke et al. (25) studied the dimensions and charac-
teristics of  the bone using computed tomography and 
histomorphometry - assessing mineral density, volume 
and the trabecular network of 30 human zygomatic bones. 
The results showed that zygomatic bone is composed of 
abundant trabecular bone, with bone density parameters 
that are not optimum for implant placement. In coin-
cidence with Rigolizzo et al. (26), they concluded that 
implant anchoring success in zygomatic bone is afforded 
by the great stability resulting from contact with at least 
four cortical layers (27). 
A surgical splint can be used for placement of the Zygo-
ma® implants. Van Steenberghe et al. (28) evaluated the 
accuracy of surgical perforation guides in placing implants 
within zygomatic bone. They placed 6 fixations measuring 
45 mm in length in three human cadavers, employing 
three-dimensional planning software that uses the images 
obtained by computed tomography and simulates the 
position of the zygomatic implants. The surgical guides 
were custom manufactured based on three-dimensional 
reconstructions of the zygomatic-maxillary complex. On 
comparing the pre- and postoperative tomographic sec-
tions, the authors found the deviation to be less than 3º 
in 4 of the 6 cases. Vrielinck et al. (20), in 29 patients used 
surgical guides obtained by stereolithography, for placing 
67 zygomatic implants. They reported a 93% success rate 
with two failures attributable to apical excess emergence 
of the implants. In addition, one patient developed a buc-
cosinusal fistula secondary to defective surgical closure, 
and two patients suffered chronic gingivitis around the two 
zygomatic implants. These complications were not con-
sidered failures, since the implants remained functional. 
This study showed a mean deviation in implant inclination 
of 2.7 mm, and of 5.14º for the zygomatic implants in their 
apical portion. The authors recommended using surgical 
perforation guides for zygomatic implant placement, due 
to the long lengths of these implants and the anatomical 
peculiarities of the receptor zone (14).
Al-Nawas et al. (29) investigated the peri-implant soft 
tissue alterations of 37 zygomatic implants placed in 24 
patients between 1998-2001. The evaluation was made 
over an average of 598 days. Periodontal colonization by 
pathogenic microorganisms was detected in 20 implants. 
Nine of the 20 implants showed bleeding in response to 
probing, and four of these 9 implants yielded positive mi-
crobiological results. The mean probing depth was 1 mm 
greater palatine and mesial compared with the vestibular 
and distal aspects. Another 9 implants showed bleeding 
and pockets of 5 mm or more - this resulting in a reduction 
of the implant success rate to 55%. Such potential peri-
implant soft tissue alterations must be taken into account 
when deciding to use zygomatic implants as a management 
alternative in patients with atrophic maxilla. 
Esposito et al. (30) conducted a review of the literature 
to compare the results of zygomatic implant placement 
without bone augmentation techniques versus conven-
tional dental implants placed after bone augmentation, 
in patients with severe maxillary reabsorption and a 
minimum follow-up of one year. They found no rando-
mized study contrasting these two procedures; as a result, 
no conclusions could be drawn based on the scientific 
evidence. The authors likewise indicated that the studies 
advocating zygomatic implants as treatment alternative 
for upper jaws with bone deficiencies are not long-term 
surveys, since the technique is relatively new. However, 
zygomatic implants appear to offer high percentage sur-
vival over the short term in severely reabsorbed bone, as 
reflected by the reviewed series that point to the need for 
long-term multicenter studies.
In our series the zygomatic implant survival rate was 
96.04%, comparable to the results published in the lite-
rature. The use of these implants lessened the need for 
extensive bone grafting, shortened hospital stay, and re-
duced postoperative morbidity and pain. It is important 
to note that this procedure is not without complications, 
and requires thorough knowledge of the technique and 
great surgical skill. The advantages seen in clinical prac-
tice define zygomatic implants as an effective treatment 
alternative for the management of patients with atrophic 
upper maxilla.
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